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health, Mental health, Sexuality, and Couple Relationship, being the first dimen-
sion composed by 3 sub-dimensions: vasomotor symptoms, health, and Aging. 
Goodness-of-fit statistics were better than those of the extended version (chi-
square/df= 2.130, AGFI= 0.859, PCFI= 0.919, RMSEA= 0.044). Internal consistency was 
good (Cronbach’s alpha= 0.830) but slightly lower than that of the original scale. 
Correlations between extended and reduced subscales was high and significant in 
all cases (p< 0.001), ranging from r= 0.857 for Aging to r= 0.971 for Vasomotor symp-
toms. ConClusions: The Cervantes scale may be reduced to an abridged version 
of 14-item (Cervantes-SF) which maintains the original dimensional structure and 
psychometric properties. This version extends 45% of the original length, being 
faster to apply and making it specially suitable for routine medical practice.
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objeCtives: To assess the patients’ and their accompanying family members or car-
ers’ value attributes and perceptions about GD when compared to the corresponding 
brand name drugs (BD). Methods: A total of 25 patients and 25 accompanying 
persons were consecutively selected and interviewed while visiting 6 commercial 
pharmacies located in different regions of São Paulo city. Also 25 patients and 25 
accompanying persons were consecutively selected and interviewed while waiting 
for their regular outpatient visits at the university outpatient clinic. The question-
naire consisted of questions regarding socio-economic, demographic and educa-
tional items, quality of life (QoL), and the interviewee perception regarding the 
value attributes of GD when compared to BD. The study was approved by the local 
ethic committee. Results: Respondents were predominantly women (57%) and 
the mean age was 54 years. Additionally, 55% relied exclusively in public health 
care system and 55% were regularly employed. Mean QoL as assessed by SF-6D was 
0,74. Respondents overwhelmingly (99%) believed GD to be cheaper than BD. Some 
36% and 63% also reported GD to be less and equally effective, respectively, as 
compared to BD. GD were perceived as either safe or less safe than BD in 46% 
and 46%, respectively. Some 74% of the sample agreed with the statement that 
they would prefer to take a BD if there was no price difference to the GD, and 85% 
admitted they regularly compare the prices of BD and GD before deciding which 
drug to buy. ConClusions: Multiple factors may contribute to the decision to buy 
a GD. Among these perceived effectiveness, safety and price appear to be the most 
important factors. Further studies are needed to better understand the decision-
making process regarding GD use and its consequences for the health care system 
and families.
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objeCtives: The Israeli National List of Health Services (NLHS) offers a generous 
coverage for drugs and other technologies. However, not all approved drugs are 
covered under the basic health insurance and are frequently subject to out-of-
pocket payments. We assessed the ex-ante willingness to pay (WTP) for a more 
generous public coverage for life-extending medications. Methods: We con-
ducted a telephone survey among a representative sample of the adult population 
in Israel (n= 502). We asked participants to indicate whether they will be willing to 
pay an increased health tax assuring that all life-extending interventions will be 
covered and provided by their health insurance plans with no cost-sharing. We 
also collected information on respondent age, gender, income, education, self-
rated health and coverage of supplementary/private health insurance. Results: 
Mean age of the study population was 51.7±15.9 years. 63.5% indicated that they 
would be willing-to-pay an increased health tax for a generous public coverage 
of medications. Respondents willing-to-pay were younger (49.3±15.0 vs. 55.9±16.4 
years; p< 0.001), reported a higher self-rated health (p= 0.001), and WTP increased 
with respondent’s income (p= 0.005), and were also covered by a commercial 
health insurance (p= 0.002). Among all respondents (WTP set at zero for those 
unwilling to pay) the median extra monthly WTP was in the range of 0-$7. The 
independent predictors for WTP identified in the logistic regression analysis were: 
respondent age (OR= 0.974; 95% CI 0.960-0.989); and being Jewish (OR= 2.997; 95% CI 
1.745-5.147). ConClusions: Additional sources of funding should be identified 
and allocated to allow a more generous coverage of life-extending medications. 
Respondents are willing-to-pay extra health taxes (up to 7.5% of the current aver-
age health tax) to assure that all life-extending interventions are included in the 
NLHS at no co-payment. While these potential extra funds are sufficient to cover 
a wide range of technologies it is unlikely that the health tax will be raised in 
Israel in the near future.
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objeCtives: To assess WTP of patients and accompanying family members or car-
ers for a brand name drug (BD) as compared to a GD for treating an acute and a 
chronic condition. Methods: A total of 25 patients and 25 accompanying family 
members or carers were consecutively selected and interviewed while visiting 6 
commercial pharmacies located in different regions of São Paulo city. Also another 
25 patients and 25 accompanying family members or carers were consecutively 
selected and interviewed while waiting for their regular outpatient visits at the uni-
versity outpatient clinic. A questionnaire with 2 hypothetical scenarios describing 
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a Parent-adMInIstered but cHIld-coMPleted PatIent-rePorted 
outcoMe (Pro) ProVIdes a Measure WItH content ValIdIty tHat Is 
ValId and relIable for use In cHIldren aGed 6 to 11 years
Arbuckle R., Marshall C.
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objeCtives: Collecting data about symptoms and health-related quality of life 
impacts in children aged 6-11 is particularly challenging. Children themselves do not 
necessarily have the reading skills or the cognitive and recall capacity to self-report 
on their own, but equally parents are not always with their child or may not observe 
them closely enough and some symptoms are not observable. To overcome these 
challenges we developed a parent-administered child-report symptom measure in 
which the parents helped the child read and understand the PRO items. Methods: 
Iterative rounds of qualitative concept elicitation and cognitive debriefing inter-
views with children (aged 6-11) and parents supported the development and refine-
ment of daily diary instructions, items and response scales. The resulting items 
were included in an observational study of 185 children (aged 6-11) who completed 
the diary at home for seven days in order to support the development of scoring 
and psychometric validation. Feedback on the draft scales was obtained from both 
children and parents following the at-home completion phase, with the parent 
survey and debriefing focusing on how much help they had provided to the children 
in regards to reading, understanding, recalling and responding during the seven 
days. Results: The diary questions were developed to be completed by the child, 
but instructions indicated that the parent could help the child read and understand 
them. Observation of parents helping the child and subsequent debriefing provided 
evidence that parental help aided the child in recalling accurately. However, the 
children did push back if they disagreed with their parent’s suggested response, 
suggesting they were not unduly influenced. Subsequent psychometric validation 
confirmed that this approach and the refined items provided valid, reliable and 
responsive scores. ConClusions: This PRO development provides evidence that 
a parent-assisted child self-report symptom measure had strong content validity 
and was valid, reliable and responsive to changes over time.
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objeCtives: To identify effective reminder strategies, survey data focused on 
patient preferences for reminders in Patient Reported Outcomes (PRO) studies was 
investigated. This presentation will share these results to provide recommenda-
tions for patient reminder strategies to optimize patient compliance and data 
quality. Methods: A survey was completed in 2013, involving patients who par-
ticipated in at least one clinical study in the past two years that required patient 
diaries. The survey sought to establish patient preferences (modality/timing) for 
receiving diary reminders based on their experiences, including an evaluation on 
their personal technology behaviors. Results: Responses were provided by 405 
patients. The patients stated their reasons for non-compliance of their patient 
diaries: 51.4% reported “non-compliance due to forgetting”; 41.1% reported “being 
too busy”; 27.6% reported “a lack of diary access”; and 2.7% reported “other rea-
sons”. Patients also stated their modality preferences for reminders. The preferred 
choice was text messages (67.2%); followed by hand-held alerts (34.3%); phone calls 
(34.1%); calendar alerts (32.6%); and email (6.2%). Although the majority of patients 
indicated checking text messages and emails daily, significantly more patients 
checked text messages immediately when compared to email (52.9% vs. 15.1%) 
suggesting that text messages would be a more effective way to remind patients. 
The majority of patients wanted to be reminded of their diary assessments (97.3%), 
appointments (95.8%), and medication dosing (95.0%). ConClusions: As the top 
reason for non-compliance was “forgetting”, this suggests that reminders can be 
helpful in improving compliance. Results show that patients prefer to be reminded, 
also suggesting that reminders can improve compliance. Technology behaviors 
suggest that text messages could be an effective way to remind patients. Patient 
preferences for reminders should be given careful consideration – since incor-
porating optimal reminder strategies can likely improve the patient experience, 
compliance and data quality.
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objeCtives: The Cervantes scale is a specific health-related-quality-of-life (HRQoL) 
questionnaire developed in Spanish women through and beyond menopause. The 
original scale contains 31-items and it is time-consuming in the routine medical 
practice. The aim of this work was to reduce the 31-item scale and to produce an 
abridged version with the same dimensional structure and similar psychometric 
properties. Methods: A representative sample of 563 women [mean age 60 years 
old (SD= 6.7, Min= 46, Max= 82)] extracted from the Ginerisk study was used. The 
Ginerisk was an epidemiological, cross-sectional study carried out in 4,157 Spanish 
post-menopausal women attending out-patient clinics of Gynecology throughout 
Spain in year 2011. Item analysis, internal consistency reliability, item-total and 
item-domain correlations and item correlation with the generic Spanish version 
of the MOS-SF12v2 questionnaire dimensions were initially studied. Dimensional 
Confirmatory Factor Analysis (CFA) and Full-model CFA were used to check struc-
ture stability. A 3-fold cross-validation method was used to obtain stable estimates, 
by means of multi-group analysis. Results: The scale was reduced to a 14-items 
version: The Cervantes-SF, containing four main dimensions: Menopause and 
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pregnancy outcomes. Methods: To determine whether additional clinical tests, 
advice, planning, management or pregnancy follow-up were recommended for 
obese women during pregnancy,Clinical Practice Guidelines (CPGs) were collated 
from across the Endocrinology and Obstetrics National Societies websites of 
the 9 European countries participating in the FP7 DALI study (Austria, Belgium, 
Denmark, Ireland, Italy, The Netherlands, Poland, Spain, UK). This was comple-
mented by a Medline search and a survey among the investigators of the DALI 
study. Results: Fifteen CPG for 9 countries were retrieved. All but Spanish guide-
lines, which recommend O’Sullivan test, recommend OGTT 75g to detect GDM in 
obese women. Most of them include 24-28 weeks as the time for OGTT, but other 
schedules are also used, especially when risk factors other than obesity are pre-
sent. Other common recommendations for obese women in European CPGs were 
diet advice (included in the guidelines of 6 different countries), special birth plan-
ning (5 countries), exercise and other lifestyle recommendations (4 countries) and 
vitamin D supplementation, multidisciplinary follow-up (including endocrinolo-
gist or diabetologist) and additional ultrasound scan (3 countries). ConClusions: 
Recommendations for obese women in the studied countries are heterogeneous 
and in many cases do not include actions beyond screening for GDM. Existing 
guidelines will be reviewed in the light of the findings from the interventions 
studied in the framework of the DALI study.
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objeCtives: Infertility affects 14% of couples in reproductive age in Spain. 
Progressive population ageing leads the assessment of policies that favor birth-
rates. The objective is estimating the lifetime economic benefits of publicly 
financing assisted reproductive therapies (ART) in Spain, by calculating the 
return on this investment. Methods: Generational accounting model that 
simulates the flow of taxes paid by the individual minus those direct govern-
ment transfers received (e.g. health care, education, pensions) over the lifecycle 
of a child. The cost of ART was calculated as the average cost of conceiving a 
child through currently available ART in Spain. The difference between dis-
counted transfers and taxes minus the cost of ART equals the net present value 
(NPV) of a child conceived by ART. Year 2006 was set as the base case because 
of its macroeconomic stability. A 3.5% discount rate was applied. Sensitivity 
analysis tested robustness of results under different scenarios. Results: An 
ART-conceived child would contribute € 534,624 in net taxes to the government 
and would receive € 479,952 in governmental transfers over her lifecycle. After 
discounting the cost of ART (9,000€ ) the NPV is estimated at € 45,672. Each Euro 
invested in subsidizing ART reverts into fiscal benefits of € 5. Sensitivity analy-
sis shows that even in extreme macroeconomic scenarios, the long-run NPV 
of an ART-conceived child ranges between € 11,233 and € 62,470. The return on 
investment varies between € 1.25 y € 6.94 € for each Euro invested in ART. The 
break-even age at which the financial position begins to be favorable to the 
Spanish Treasury was set at 34-42 years. ConClusions: Generational account-
ing models allow estimating long-term fiscal implications of public funding of 
ART. Each Euro invested in subsidizing ART reverts into fiscal benefits of € 5. 
Thus, investment in ART leads to substantial discounted future fiscal revenue 
for the Spanish Treasury, notwithstanding its beneficial psychological effect 
for infertile couples.
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Would a neW tHeraPy for cHIldren be refused In tHe context of tHe 
GerMan aMnoG?
Walzer S., Droeschel D.
MArS Market Access & Pricing Strategy UG (h.b.), Weil am Rhein, Germany
objeCtives: The new German law AMNOG was introduced in 2011. According to 
it all newly launched therapy options would need to be evaluated by the Institute 
for Quality and Efficiency in health care (IQWIG) and the joint federal committee 
(Gemeinsamer Bundesausschuss, GBA) before a final price negotiation will happen. 
Given the specific characteristics of pediatric patients it is uncertain if a new drug 
for those patients would successfully pass the AMNOG process. Methods: The 
AMNOG evaluation criteria were applied to the specifics of pediatric drugs. A special 
focus was given to the benefit assessment method, clinical trial designs and the 
AMNOG process. Results: Current HTA evaluation methods being applied to medi-
cal therapies, in general, need to be modified when applied to pediatric therapies. 
For example, traditional benefit evaluations that require randomized clinical trials 
are standard but cannot always be fulfilled in this patient population. In pediatric 
development programs one-arm studies are standard with surrogate endpoints in 
order to minimize the exposure of children to an experimental therapy. Additionally 
the naturally low sample size within pediatric indications linked to the different 
natural subgroups of children (babys, toddlers, etc.) make a formal additional ben-
efit proof even harder. Hence from a benefit assessment perspective the clinical 
study design, sample size and choice of endpoint are most crucial but could hardly 
be executed in pediatric trials. With respect to the AMNOG process only pediatric 
trials in orphan disease could pass successfully given the exception rules for the 
additional benefit. ConClusions: If the German health care system is to secure 
the full benefits of potential new pediatric therapies, it will need to provide a similar 
process as it is granted for orphan drugs.
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an acute condition (acute tonsillitis in an 8 year old child) and a chronic condition 
(an adult with diabetes mellitus type 2) was developed. WTP for a BD as compared 
with a GD was assessed in both scenarios using the payment scale and the open-
ended formats. The study was approved by the local ethical committee. Results: 
Respondents were predominantly women (57%) and the mean age was 54 y.o. A 
family income of less than R$ 1.356,00 was reported by 16%. For the total study 
sample, the maximum WTP for a BD (over and above the mean retail price of a GD) 
for the acute and chronic case scenarios were on average R$ 27,54 and R$ 21,04 
when measured by the payment scale and R$ 36,54 and R$ 24,77 when measured 
by the open-ended question, respectively. These values are 36% to 65% above the 
mean retail prices of the corresponding GD. ConClusions: Patients and accom-
panying persons were willing to pay considerably more for the BD when compared 
to GD. This may be driven by the perception of higher perceived effectiveness and 
safety of BD.
IndIVIdual’s HealtH – Health care use & Policy studies
PIH52
ProtectIVe factors for unIVersIty students’ HealtH
ViÂšnjiÄ‡ A.1, VeliÃ„ÂkoviÃ„Â V.1, SokoloviÄ‡ D.2, Ranđelović S S.3, MilovanoviÃ„Â Â M.4
1University in NiÂš, Medical Faculty, NiÂš, Serbia and Montenegro, 2University in Niš, Medical 
Faculty, NiÂš, Serbia and Montenegro, 3Viborg County Hospital, Viborg, Denmark, 4Clinical Centre 
in NiÂš, Serbia and Montenegro
objeCtives: To assess which of the studied factors were positively associated with 
the students’ health and to investigate which of these factors stood out as the most 
important protective factors for their health. Methods: Data were obtained from 
a cross-sectional study conducted during the academic 2011/2012th at the universi-
ties in Niš, Belgrade and Novi Sad, which surveyed a total of 2285 students of both 
sexes. This study examines variables such as physical, psychological and social 
health, protective factors and risk factors. Students were assessing their own health 
answering the questionnaire. Results: Only 11.8% of the surveyed students have 
assessed their health as excellent, 72.5% as very good or good, and 15.7% as poor or 
very poor. Better health status was positively correlated with the quality of sleep, 
the existence of free time, physical and social activities, religiosity and built health 
values in all three universities. Kruskal-Wallis H test showed that better students are 
more satisfied with their life (p < 0.001), that better assess their health (p < 0.01) and 
less drink alcoholic beverages. Female students had more physical pain, were more 
frequently depressed than men, they were more easily tired, they were much more 
nervous and had more problems than men with sleep. Men assessed their health as 
better than female students. However, the satisfaction scale (χ 2 homogeneity test; 
p < 0.001) were found females to be more satisfied with their lives than male stu-
dents. ConClusions: General health is affected by various physical, psychological 
and social aspects of health. The results show that there are significant protective 
factors for better social, psychological and general health in students that may be 
affected. Therefore, health promotion decision makers should adopt contemporary 
strategies that will in the future put emphasis on the social and psychological 
components of students’ health.
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objeCtives: Uterine fibroids (UF) affect approximately 20% to 40% of repro-
ductive-aged women. The mainstay of treatment of symptomatic UF is surgical. 
Myomectomy surgically removes UF while preserving the uterus. However, hyster-
ectomy that is considered to be the definitive treatment of UF, causes infertility.The 
aim of our study was to analyze the prevalence of hysterectomy in Hungary among 
reproductive-aged women with UF to assess the societal burden due to lost fertil-
ity. Methods: Database were analyzed. Surgical procedures for the treatment of 
UF (ICD-10: D25), in 20-45 years old women between 2007 and 2012 were analyzed 
based on the Hungarian National Health Insurance Fund database. Economic bur-
den of lost fertility was assessed by the human capital approach. Present value of 
life for a newborn child was calculated by applying 2011 GDP per capita and 3.7% 
discount rate. Results: Among 11,095 women with surgical procedure related 
to UF the prevalence of hysterectomy was 61.5% (n= 6827). Most hysterectomised 
women (n= 4781) were 40-45 years old; unexpectedly a significant number of 20-40 
years old women with UF had hysterectomy (n= 2046). Present value of a newborn 
child was 262,314 EUR in 2011. ConClusions: Our results indicate that immediate 
hysterectomy, even in women under 40 years, is still a frequently performed surgi-
cal procedure for the treatment of UF. The macroeconomic consequences of lost 
fertility due to hysterectomy in reproductive-aged women with UF are significant. 
Even only one additional child-birth due to avoided hysterectomy would result in 
significant societal and economic benefits. Further scientific evaluations are needed 
to define more accurately the long term macroeconomic impact of preserved fertil-
ity in women with UF.
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1LASER Analytica, Oviedo, Spain, 2Addenbrooke’s Hospital, Cambridge, UK, 3VUmc, Amsterdam, 
The Netherlands
objeCtives: To review, within the framework of the FP7 DALI (Vitamin D And 
Lifestyle Intervention for Gestational Diabetes Mellitus (GDM) Prevention) study, 
guidelines for the management of obese women during pregnancy across Europe 
to assess the specificity of the recommendations in this group at risk of adverse 
